Samyang Biopharm Corporation (KRX:0120G0)
South Korea · Delayed Price · Currency is KRW 40,400
-600 (-1.46%)
Last updated: Jul 21, 2026, 1:48 PM KST
Samyang Biopharm Market Cap
Samyang Biopharm has a market cap or net worth of 304.87 billion as of July 20, 2026.
Market Cap
304.87B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
40,400.00
ChartMarket Cap Chart
Since November 24, 2025, Samyang Biopharm's market cap has increased from 224.56B to 304.87B, an increase of 35.76%. That is a compound annual growth rate of 59.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 304.87B | -21.90% |
| Dec 30, 2025 | 390.38B | 73.84% |
| Nov 24, 2025 | 224.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CLASSYS | 2.86T |
| SD Biosensor | 740.44B |
| BioNote | 461.43B |
| T&L Co., Ltd. | 403.26B |
| Vieworks | 189.03B |
| Shinhung | 128.63B |
| Dongbang Medical | 123.93B |
| EOFLOW | 51.11B |